EUVIMEDEUVIMED entdecken
Crossref

Discovery of a potent ROR1 inhibitor using μs-scale MD simulations, wt-metadynamics, and absolute binding free energy calculations

Shradheya R R Gupta, Rashmi Rameshwari, Indrakant Kumar Singh

Journal of Molecular Modeling · 2025

DOI: 10.1007/s00894-025-06508-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular Modeling, 2025. Verfasst von Shradheya R R Gupta und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, SET, Manav Rachna International Institute of Research and Studies, Faridabad, Haryana, 121004, India. Hauptthemen laut MEDLINE: Molecular Dynamics Simulation, Receptor Tyrosine Kinase-like Orphan Receptors, Protein Kinase Inhibitors, Drug Discovery. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CONTEXT: Receptor tyrosine kinase-like orphan receptor 1 (ROR1) is a cancer-associated pseudokinase with low expression in normal adult tissues but elevated levels in various malignancies, making it a promising therapeutic target. Among ~ 4 million compounds, CHEMBL3926946 emerged as the most promising candidate, demonstrating a persistent binding pose and a well-defined free energy basin. Well-tempered metadynamics (wt-MetaD) revealed a deep minimum of 26.00 ± 2.44 kcal/mol, indicating a highly stable interaction. CHEMBL3926946 exhibited a favourable Absolute Binding Free Energy Perturbation (ABFEP) of - 16.52 ± 0.37 kcal/mol, significantly outperforming the inhibitor Ponatinib (- 8.67 ± 0.94 kcal/mol), supported by persistent interactions with GLU523 and LEU479. This study highlights CHEMBL3926946 as a robust lead for ROR1-targeted cancer therapy and emphasizes the utility of combining wt-MetaD and ABFEP for reliable hit prioritization. METHODS: We employed a multilayered in silico pipeline integrating high-throughput virtual screening, long-timescale molecular dynamics (MD), wt-MetaD, and ABFEP. Ligands and protein were prepared using the OPLS2005 force field, and all stages up to wt-MetaD were conducted in Maestro (v12.8.117) using the same force field. A library of ~ 4 million compounds yielded 137 candidates, Further shortlisted via MD. 7 high-confidence molecules underwent 5 independent MD replicates with randomized seeds to ensure statistical robustness. The top 3 compounds were validated by 1 μs (1000 ns) simulations to assess long-term conformational stability and wt-MetaD to reveal deep minimum. ABFEP calculations were performed using the CGenFF force field in NAMD 3.0. We benchmarked ABFEP protocol against experimentally validated ligands, successfully reproducing experimental binding free energies (ΔG), confirming the protocol's predictive reliability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Molecular Dynamics SimulationReceptor Tyrosine Kinase-like Orphan ReceptorsProtein Kinase InhibitorsDrug DiscoveryHumansThermodynamicsProtein BindingMolecular Docking SimulationLigandsPyridazinesBinding SitesImidazoles

Stichwörter der Autor:innen

ABFEPDrug discoveryMetadynamicsROR1 protein

Substanzen

Receptor Tyrosine Kinase-like Orphan ReceptorsROR1 protein, humanProtein Kinase InhibitorsLigandsPyridazinesponatinibImidazoles

Autor:innen und Institutionen

  • Department of Biotechnology, SET, Manav Rachna International Institute of Research and Studies, Faridabad, Haryana, 121004, India.
  • Department of Biotechnology, SET, Manav Rachna International Institute of Research and Studies, Faridabad, Haryana, 121004, India. rashmi.set@mriu.edu.in.
  • Molecular Biology Research Lab, Department of Zoology, Deshbandhu College, University of Delhi, Kalkaji, New Delhi, 110019, India. iksingh@db.du.ac.in.
  • Molecular Biology & Health Informatics Lab, Dr. B. R. Ambedkar Center for Biomedical Research, University of Delhi, Delhi, 110007, India. iksingh@db.du.ac.in.
  • Delhi School of Public Health, Institute of Eminence, University of Delhi, Delhi, 110007, India. iksingh@db.du.ac.in.

Zitieren

APA

Gupta, S. R. R., Rameshwari, R., & Singh, I. K. (2025). Discovery of a potent ROR1 inhibitor using μs-scale MD simulations, wt-metadynamics, and absolute binding free energy calculations. Journal of Molecular Modeling. https://doi.org/10.1007/s00894-025-06508-3

Vancouver

Gupta SRR, Rameshwari R, Singh IK. Discovery of a potent ROR1 inhibitor using μs-scale MD simulations, wt-metadynamics, and absolute binding free energy calculations. Journal of Molecular Modeling. 2025. doi:10.1007/s00894-025-06508-3

BibTeX
@article{Gupta2025,
  author = {Gupta, Shradheya R R and Rameshwari, Rashmi and Singh, Indrakant Kumar},
  title = {Discovery of a potent ROR1 inhibitor using μs-scale MD simulations, wt-metadynamics, and absolute binding free energy calculations},
  journal = {Journal of Molecular Modeling},
  year = {2025},
  doi = {10.1007/s00894-025-06508-3}
}
Kostenlos starten →